The Manila Times

Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle™ Platform ...

Revolution Medicines, Inc.: European Medicines Agency Expedites Assessment of Revolution Medicines' Daraxonrasib Under Phased Review Process

Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial R ...
enewscourier.com

Limestone County farmer selected for A.L.F.A. Leaders program

Hunter Rogers, an agriscience teacher in Limestone County, has been selected to participate in Class VII of Agricultural ...
The Manila Times

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...